{"altmetric_id":3621109,"counts":{"readers":{"mendeley":8,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:26613822"],"posts_count":1}},"citation":{"abstract":"To compare the relative efficacy and safety of lesopitron 4-80 mg\/d versus lorazepam 2-4 mg\/d and placebo in a subgroup of patients with anxiety history taken from a larger study of patients with a primary diagnosis of generalized anxiety disorder (GAD).","abstract_source":"pubmed","altmetric_jid":"4f6fa5e63cf058f610005728","authors":["A Fresquet","M Sust","A Lloret","M F Murphy","F J Carter","G M Campbell","G Marion-Landais"],"doi":"10.1345\/aph.19041","first_seen_on":"2015-02-14T14:11:15+00:00","handles":[],"isbns":[],"issns":["1060-0280"],"issue":"2","journal":"Annals of Pharmacotherapy","last_mentioned_on":1268992278,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10676820"],"pmid":"10676820","pubdate":"2000-02-01T00:00:00+00:00","publisher":"SAGE Publications","publisher_subjects":[{"name":"Pharmacology And Pharmaceutical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["pharmacology","drugtherapy"],"title":"Efficacy and safety of lesopitron in outpatients with generalized anxiety disorder.","type":"article","volume":"34","mendeley_url":"http:\/\/www.mendeley.com\/research\/efficacy-safety-lesopitron-outpatients-generalized-anxiety-disorder"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3629910,"mean":4.9315517540573,"rank":816271,"this_scored_higher_than_pct":63,"this_scored_higher_than":2290961,"rank_type":"exact","sample_size":3629910,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":96218,"mean":8.2159450616837,"rank":25122,"this_scored_higher_than_pct":72,"this_scored_higher_than":70019,"rank_type":"exact","sample_size":96218,"percentile":72},"this_journal":{"total_number_of_other_articles":1205,"mean":3.0234186046512,"rank":300,"this_scored_higher_than_pct":64,"this_scored_higher_than":783,"rank_type":"exact","sample_size":1205,"percentile":64},"similar_age_this_journal_3m":{"total_number_of_other_articles":17,"mean":4.61875,"rank":9,"this_scored_higher_than_pct":47,"this_scored_higher_than":8,"rank_type":"exact","sample_size":17,"percentile":47}}},"demographics":{"users":{"mendeley":{"by_status":{"Student  > Doctoral Student":1,"Student  > Ph. D. Student":2,"Student  > Postgraduate":1,"Other":1,"Student  > Bachelor":1,"Lecturer > Senior Lecturer":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":4,"Chemistry":1,"Psychology":2,"Pharmacology, Toxicology and Pharmaceutical Science":1}}}},"posts":{"wikipedia":[{"title":"Lesopitron","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=350761243#altmetric_citation_2","license":"public","citation_ids":[3621109,3621109,3621109],"posted_on":"2010-03-19T09:51:18+00:00","summary":"Lesopitron (E-4424) is a selective full agonist of the 5-HT1A receptor which is structurally related to the azapirones.","page_url":"http:\/\/en.wikipedia.org\/?curid=26613822","wiki_lang":"en","author":{"name":"Vanished 45kd09la13","url":"http:\/\/en.wikipedia.org\/wiki\/User:Vanished 45kd09la13"}}]}}